| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967440 | Vaccine | 2013 | 10 Pages |
Abstract
Decision makers in lower income countries lack economic data to support influenza vaccine policy decisions, especially of pregnant women. Standardized cost-effectiveness studies of influenza vaccination of WHO-recommended risk groups' methods are urgently needed.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Samuel K. Peasah, Eduardo Azziz-Baumgartner, Joseph Breese, Martin I. Meltzer, Marc-Alain Widdowson,